National Kidney Foundation Innovation Fund
National Kidney Foundation Innovation Fund is an investor named in the Raise Track Update as participating in Estuary Biotherapeutics' Series A.
- Type
- Venture capital firm
About
The National Kidney Foundation Innovation Fund participated in Estuary Biotherapeutics' $93 million Series A, announced on 2026-10-16. RA Capital Management led. 4BIO Capital's post says the National Kidney Foundation and does not add the words Innovation Fund. The company release and the Raise Track Update use National Kidney Foundation Innovation Fund. This page uses that name.
The Raise Track Update names National Kidney Foundation Innovation Fund as an investor in: Estuary Biotherapeutics (2026-10-19).
This page is not indexed by search engines yet. It is promoted once it meets the quality gate for investor pages: a description from the firm's own website, a headquarters city and at least two two-sourced rounds on this site.
Funding rounds on RaiseTrack
| Company | Round | Date | Role |
|---|---|---|---|
| Estuary Biotherapeutics | Series A 2026 | 2026-10-16 | participant |
Sources
Last verified:
- https://estuarybio.com/news/estuary-series-a
Type: company announcement. Accessed 2026-10-19.
Estuary Biotherapeutics release, 16 October 2026. Names the National Kidney Foundation Innovation Fund as a participant in the Series A. - https://www.4biocapital.com/single-post/estuary-biotherapeutics-launches-with-103-million-to-advance-targeted-gene-therapies-for-kidney-dis
Type: official investor website. Accessed 2026-10-19.
4BIO Capital post, 16 October 2026. Says the National Kidney Foundation, without the words Innovation Fund. This page uses National Kidney Foundation Innovation Fund. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-19/
Type: other verified public source. Accessed 2026-10-19.
Raise Track Update for 2026-10-19. Names this firm on Estuary Biotherapeutics' $93 million Series A.